These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18161885)

  • 1. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
    Shayeganpour A; Hamdy DA; Brocks DR
    Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
    Shayeganpour A; El-Kadi AO; Brocks DR
    Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats.
    Wyss PA; Moor MJ; Bickel MH
    J Pharmacol Exp Ther; 1990 Aug; 254(2):502-7. PubMed ID: 2384884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration.
    Kotake T; Takada M; Goto T; Komamura K; Kamakura S; Morishita H
    J Clin Pharm Ther; 2006 Jun; 31(3):237-43. PubMed ID: 16789989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of CYP1A induction on amiodarone disposition in the rat.
    Elsherbiny ME; Brocks DR
    J Pharm Sci; 2010 Jan; 99(1):539-48. PubMed ID: 19718765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
    Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
    In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat.
    Shayeganpour A; Korashy H; Patel JP; El-Kadi AO; Brocks DR
    Int J Pharm; 2008 Sep; 361(1-2):78-86. PubMed ID: 18599227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.
    Li HL; Zhang WD; Zhang C; Liu RH; Wang XW; Wang XL; Zhu JB; Chen CL
    J Pharm Biomed Anal; 2006 Jun; 41(4):1342-6. PubMed ID: 16644173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
    Shayeganpour A; Jun AS; Brocks DR
    Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.
    Teng R; Sarich TC; Eriksson UG; Hamer JE; Gillette S; Schützer KM; Carlson GF; Kowey PR
    J Clin Pharmacol; 2004 Sep; 44(9):1063-71. PubMed ID: 15317834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
    Young RA; Mehendale HM
    Drug Metab Dispos; 1986; 14(4):423-9. PubMed ID: 2873989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals].
    Gaete LE; Ortiz M; Soto J; Saavedra I
    Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of amiodarone and desethylamiodarone cytotoxicity in nontransformed human peripheral lung epithelial cells.
    Mulder JE; Brien JF; Racz WJ; Takahashi T; Massey TE
    J Pharmacol Exp Ther; 2011 Feb; 336(2):551-9. PubMed ID: 21078785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.